by Dr. Phil Baker, PHARMD | Oct 8, 2025 | Haloscrips, Homepage, Population Health
Employer-sponsored health plans cover more than 150 million Americans. But amid exponentially rising costs, many employers are considering alternatives to the existing model. Enter the self-funded health plan. If you ask Google, you’ll see self-funded plans described...
by Dr. Phil Baker, PHARMD | Sep 26, 2025 | Haloscrips, Homepage, Population Health
Employer-sponsored health insurance is a staple of many employee benefits packages. These plans covered more than 150 million Americans in 2024, according to research by the Kaiser Family Foundation. Behind salaries, it’s usually one of any organization’s largest...
by Dr. Phil Baker, PHARMD | Jan 30, 2025 | Haloscrips, Population Health
Download the PDF Send download link to: As we step into 2025, the pharmacy profession finds itself navigating a rapidly changing landscape. Challenges like pharmacy deserts, workforce development, supply chain issues, and PBM reform are reshaping the industry. How...
by Dr. Phil Baker, PHARMD | Jan 17, 2025 | Haloscrips, Homepage, Population Health
Download the PDF Send download link to: A recent Wall Street Journal article, “Same Drug, 2200 Different Prices,” exposes a troubling issue: the extreme variability in pricing for generic medications. These bioequivalent drugs are manufactured by different...
by Dr. Phil Baker, PHARMD | Jan 13, 2025 | Haloscrips, Homepage, Population Health
Download the PDF Send download link to: Statins, including popular medications like Lipitor (atorvastatin) and Crestor (rosuvastatin), are among the most commonly prescribed drugs in the United States. Their ability to lower LDL cholesterol (the “bad” type) has...
by Dr. Phil Baker, PHARMD | Nov 22, 2024 | Haloscrips, Homepage, Population Health
Download the PDF Send download link to: To be honest, my heart sinks when I’m asked my opinion about the explosion of compounding pharmacies related to GLP-1 weight loss drugs (commonly known by brand names like Ozempic or Wegovy). It’s a complicated answer, and my...
